Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The World Market for Cancer Diagnostics, 5th Edition - Kalorama Information


Published on

Published in: Health & Medicine, Business
  • Login to see the comments

The World Market for Cancer Diagnostics, 5th Edition - Kalorama Information

  1. 1. The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Kalorama Information Presents A Short Preview
  2. 2. provides market research solutions to business professionals seeking to enhance their business goals. We provide a number of business intelligence solutions, from individual market research reports from over 700 leading global publishers, to Knowledge Centers where clients can discover deeper business insight products into a topic over time. Or perhaps your business needs a much wider view across multiple industries and topics, if so, our Profound solution allows you to select specific parts (graphs, tables, charts or sections) from different market research reports. Our Account Managers have in-depth knowledge of the publishers and the various types of reports in their respective industries. They give you unbiased and qualitative insights on which reports will best meet your needs. To learn more about which Market Intelligence Solution might best fit your needs, contact us for a complimentary Business Intelligence Assessment. One of our Account Managers will get right back in touch with you. About Us
  3. 3. About Kalorama Information For more than 30 years, Kalorama Information has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, healthcare, medical device, and pharmaceutical industries. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers. Kalorama Information’s reports track medical market trends, survey market players, and provide a comprehensive analysis of each market with both the vital market data and cogent, plain-English interpretation and insight. Our research is written by industry experts who offer insight on industry structure and competitive landscape, technology assessment and penetration, and emerging products and trends. Their analysis is based on both primary and secondary research as well as years of professional expertise in their respective industries. In addition to analyzing current and historical trends, our analysts predict where the market is headed over the next five to ten years.
  4. 4. The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. The phenomenon of test personalization comes under many guises – pharmacogenomic, pharmacogenetic, companion tests, and represents one of the fastest growing segments of the market for cancer tests. It has emerged fully from research into clinical practice. Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. Some personalized cancer tests are CE Marked and FDA-cleared and many more are in development. More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and are agreeing to pay for them. This report is written from the point of view of diagnostic modalities for the detection and management of cancer and in particular solid tumors. The technology to detect cancers of the blood - lymphomas, myelomas and leukemias - is mature and well established. The routine complete blood count screens for blood cell abnormalities and is followed by bone marrow analysis and flow cytometric studies of the blood cell surface markers. These to arrive at a more specific diagnosis. As such this report does not discuss area of hematological cancer diagnosis in great detail.
  5. 5. Cancer Diagnostics TOC Highlights o Cancer - Diagnosis And Therapy Management o Market Issues in the Commercialization of Cancer Diagnostics o Technological Trends that Enable the Future of Cancer Diagnostics o Market Analysis – Cancer Testing o Cancer Tests in Clinical Chemistry o Immunoassay Cancer Tests o Tissue – and Cell-based Cancer Tests o Personalized Cancer Testing Advances in Precisiong Skin Care Over Antioxidants View Report
  6. 6. For More on this Report and Additional Research Visit Or call 1-800-298-5699